Ignite Creation Date:
2024-05-05 @ 9:23 PM
Last Modification Date:
2024-10-26 @ 10:03 AM
Study NCT ID:
NCT00876031
Status:
COMPLETED
Last Update Posted:
2022-11-08
First Post:
2009-04-02
Brief Title:
Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
Sponsor:
University Hospital Tuebingen
Organization:
University Hospital Tuebingen
Study Overview
Official Title:
A Randomised Phase-III Trial of the Cooperative Weichteilsarkom Study Group CWS for Localised High-risk Rhabdomyosarcoma and Localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in Children Adolescents and Young Adults
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CWS-2007-HR
Brief Summary:
The purpose of this study is to investigate whether the addition of oral maintenance chemotherapy with O-TIE Etoposide Idarubicin Trofosfamide for 6 months improves the event free survival EFS in patients with localised high-risk RMS and RMS-like Soft Tissue Sarcoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 4033024 BfArM | OTHER | None | None |
| 2932007AMG1 Ethikkommission | OTHER | None | None |
| 2007-001478-10 | EUDRACT_NUMBER | None | None |
| A200714 Kinderkrebsstiftung | OTHER | None | None |
| 498 Krebsstudienregister | REGISTRY | Krebsstudienregister | None |